Introducing the new AltIndexLearn more

West Pharmaceutical Services (WST) Stock Analysis: AI Score & Alternative Data

Price
$352.29 +0.26%
AI Score
55Hold
Earnings
Oct 21
Market Cap
$25B
PE Ratio
45.3
52w Range
$231 – $366
$352.29 +0.26% vs prev close
WST Stock Price vs. AI Score Data gathered: August 12
3M +17.4%
55/100 AI Score
Hold
Brand
54/100
Employment
25/100
User Growth
75/100
Fundamental
63/100

Today's AI read on WST

WST alt-data: revenue climbing, business outlook lagging

Is West Pharmaceutical Services a buy right now? The alternative data says hold. This WST stock analysis is built on the 25+ alternative data signals AltIndex tracks on West Pharmaceutical Services every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 55/100: a Hold. The stock trades at $352.29 with a $25B market cap.

The bullish side of the 90-day ledger: revenue up 20.0% YoY to $840M, web traffic up 56.0% to 120K monthly visits, and Instagram followers up 6.9% to 3K followers. The drag: business outlook fell 15.5% — now 49% of employees are positive, and job postings down 5.9% to 287 open roles. That tension is what keeps the score mid-range.

WST’s broader alt-data profile also covers headcount (6K employees, according to LinkedIn), Facebook followers (6K), and sentiment (100/100). Every signal links to its own page with full history, the WST technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on WST is just below.

West Pharmaceutical Services AI Stock Analysis

West Pharmaceutical Services is a leading multinational company specializing in the manufacture of packaging and delivery systems for the pharmaceutical, healthcare, and consumer products industries. The company's portfolio includes a wide array of solutions, from rubber and plastic components to self-injection devices and syringe systems.

Analysis generated August 1, 2026.

Read the full WST deep-dive
Fundamentals, alt-data signals and the full methodology, refreshed daily.
Read full analysis

Recent West Pharmaceutical Services Stock Alerts

West Pharmaceutical Services logo West Pharmaceutical Services | August 11
Over the past few months, there has been an downward trend in the business outlook.
West Pharmaceutical Services logo West Pharmaceutical Services | July 28
Business Outlook among employees is down by 3.8% over the last month.
West Pharmaceutical Services logo West Pharmaceutical Services | July 24
Price is down by -6% in the last 24h.
West Pharmaceutical Services logo West Pharmaceutical Services | July 12
Web Traffic is up by 44.3% over the last month.
Get WST alerts in real-time
The moment Reddit spikes, sentiment flips, or insiders trade.
Sign up

West Pharmaceutical Services Alternative Data

Alternative Data Value 3m Change Trend
Webpage Traffic 120K 56.0%
Job Posts 287 5.9%
LinkedIn Employees 6K 1.2%
Employee Recommend 62 8.8%
Business Outlook 49 15.5%
Sentiment 100 0%
Reddit Mentions 0 N/A
X Mentions 1 83.3%
Stocktwits Mentions 0 100.0%
News Mentions 0 100.0%
Stocktwits Subscribers 892 4.9%
4chan Mentions 0 N/A
X Followers 3K 0%
Instagram Followers 3K 6.9%
Youtube Subscribers 1K 2.1%
Facebook Followers 6K 2.2%
Facebook Engagement 75 19.0%

About West Pharmaceutical Services (WST)

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

West Pharmaceutical Services logo
Price$352.29
Target Price$387.74
Volume63,420,177
Market Cap$25B
Year Range$231 – $366
Dividend Yield0%
PE Ratio45.3
Analyst Rating38% buy
IndustryBiotechnology

Latest West Pharmaceutical Services News

View more →

West Pharmaceutical Services Earnings & Financial Performance

View all earnings →

West Pharmaceutical Services Insider Trading Activity

View all →
Winters Chad filed to sell 1,523 shares at $0.0.
Apr 27 '26
Favorite Annette F filed to sell 16,828 shares at $0.0.
Apr 27 '26
Witherspoon Charles filed to sell 1,253 shares at $0.0.
Oct 29 '24
Witherspoon Charles filed to sell 1,478 shares at $0.0.
Oct 29 '24
Witherspoon Charles filed to sell 1,478 shares at $0.0.
Aug 19 '24

West Pharmaceutical Services Congress Trading

View all →
Politician Filing Date Type Size
Lisa McClain
Aug 13, 25 Buy $8K+
Jared Moskowitz
Mar 7, 25 Sell $8K+
Jared Moskowitz
Dec 9, 24 Sell $8K+
Ro Khanna
Oct 8, 24 Sell $8K+
Jared Moskowitz
Aug 21, 24 Buy $8K+

Frequently Asked Questions: West Pharmaceutical Services (WST)

West Pharmaceutical Services has an AltIndex AI Score of 55/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.

55/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.

Currently, the price of one share of West Pharmaceutical Services (WST) stock is $352.29 with a market cap of $25B.

As of today, West Pharmaceutical Services’s PE (Price to Earnings) ratio is 45.3.

View the latest West Pharmaceutical Services insider transactions to see recent buying and selling activity by company executives and directors.

Check the West Pharmaceutical Services congress trading page for the latest disclosed trades by U.S. senators and representatives.

AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.

The WST stock price chart above shows West Pharmaceutical Services’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full West Pharmaceutical Services technical analysis for RSI, moving averages, and more.

See the stocks similar to West Pharmaceutical Services section on this page for companies in the same industry ranked by market cap and AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.